Actionable news
All posts from Actionable news
Actionable news in TSRO: TESARO, Inc.,

ASCO abstract titles released; BioPharmX (BPMX) data now due early May

TESARO Inc (NASDAQ:TSRO) shares dropped 6% to close down at $139.01 following its release of its pricing plans for its recently approved PARP inhibitor Zejula (niraparib). The company announced Wednesday that the Wholesale Acquisition Cost (WAC) for its recently approved ZEJULA would be...